How to Afford Weight Loss Injections: What the Cost Actually Covers

You've done the sums and the monthly figure has made you hesitate

Most people searching this topic are not asking whether weight loss injections are expensive. They already know the answer. They are asking whether there is a way to make it work. Start there, because the maths depends on exactly what you are comparing.

Private treatment with a licensed medicine like Mounjaro or Wegovy involves a prescriber reviewing your medical history, confirming you meet the eligibility criteria for the medicine, and monitoring your progress at every repeat. The overview of weight loss injections on this site sets out what the clinical pathway looks like in practice. When you see a price quoted online, the first question is not whether it is low, it is what it includes. Consultation fees, prescriptions, delivery charges and any aftercare support all cost money. A headline that omits three of those four things is not a bargain; it is an incomplete figure.

Eli Lilly raised Mounjaro's UK list price from 1 September 2025. The highest dose moved from around £122 to around £330 per four-week pen at list price, and private providers' quoted prices have moved accordingly. Those figures are widely reported and factual, but they are not the full story. Earlier doses (2.5mg and 5mg) remain considerably cheaper, and most people start there. Treatment cost is not a fixed monthly figure; it rises as your dose does, which means the first few months are meaningfully less expensive than the maintenance phase.

Worth noting: if payday falls mid-month or you tend to reorder on a Monday before the week starts properly, building treatment cost into a recurring budget line is much simpler when there is no subscription auto-charging you at an inconvenient moment. That kind of flexibility matters more than it might sound.

What the NHS covers, and why many people cannot rely on it yet

NHS access to tirzepatide (Mounjaro) exists but is tightly phased. From June 2025, the first cohort eligible through NHS primary care is adults with a BMI of 40 or above who also have four or more of five specific weight-related conditions. A second cohort with a BMI of 35 to 39.9 and four or more of those conditions became eligible from around June 2026, with further expansion expected into 2027. NICE's appraisal of tirzepatide, published as TA1026, sets out the full criteria and phasing in detail.

Wegovy on the NHS requires referral into a specialist weight management service under NICE TA875, and waiting lists in many areas are long. The honest picture is that most people asking how to afford weight loss injections in the UK right now do not yet meet the NHS threshold, or they meet it but their local service has no capacity. That is not a failure of will; it is a structural fact about where the rollout currently stands.

For people in that position, a private prescription through a regulated pharmacy is the alternative. It does not require a referral. It does require a clinical assessment, that part is the law, not optional paperwork. Understanding the difference between NHS and private access helps explain why private prices exist at all, and why comparing a private price to a free NHS service is not a like-for-like comparison.

If you are curious whether you might already qualify for NHS treatment, the guide to requesting weight loss injections through your GP covers what to say and what criteria your practice will apply.

The real cost calculation: what 'affordable' means for a prescription medicine

Price is a reasonable concern. It is not, however, the right primary test when evaluating a prescription medicine. The NHS medicines page for tirzepatide sets out what the medicine does and what it requires, and none of it suggests that a lower price makes treatment safer or more effective. What matters for a prescription medicine is whether the supply is genuine, whether the prescriber is qualified, and whether there is clinical oversight if something goes wrong.

The counterpoint to the cost question is the cost of the alternative. Years of weight management programmes, supplements, meal replacements and other interventions add up, often without meaningful clinical effect. Treatment that works and is clinically supervised is not cheap, but viewed across a realistic time horizon it may be better value than it appears at the starter dose.

An honest way to evaluate any provider: ask what the stated price includes. If the answer is prescription plus medicine plus delivery plus aftercare and clinical re-review before every repeat, that price is structurally different from one that only covers the pen. Our treatment page shows how our pricing is structured, one figure, nothing added later. We are not the lowest price in the market and we have never claimed to be. A small saving on a prescription medicine is a poor trade if it comes at the cost of proper clinical oversight.

Some people also find that reading through the common questions about how the process works helps them decide whether private treatment is practical before they begin a consultation.

Practical steps if you are weighing up treatment this month

If you are trying to decide whether treatment is manageable financially, a few practical steps help. First, check your eligibility. The private licensed threshold is a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Lower BMI thresholds may apply for some ethnic backgrounds under UK guidance. A free clinical consultation tells you whether you are a candidate at all before you commit anything financially.

Second, think in dose stages rather than end-point prices. Treatment begins at 2.5mg (a dose whose job is to let your body adjust gradually) and moves upward only as your prescriber confirms it is appropriate. The monthly cost at the start of treatment is lower than the cost at the maintenance dose, so the budget question is not purely about the highest figure you have seen quoted. If you are based locally and want to understand what options are available near you, our page on weight loss injections in Bradford explains how to get started with a regulated provider in the area.

Third, consider whether the administration side feels manageable. People sometimes assume injections will be more difficult than they are. The practical guide to injecting weight loss medicines walks through what the process actually involves; for many people the technique is straightforward after the first use. If you have questions about the specific steps involved before you begin, our guide on how to use weight loss injections covers the process in detail, from preparing the pen to choosing an injection site. For those who prefer a non-injection route, the oral semaglutide tablet (Wegovy tablets) became the first oral GLP-1 medicine licensed in the UK for weight management in June 2026, worth knowing if the injection element is the barrier rather than the cost. Some people also ask specifically about using the tummy as an injection site for weight loss treatment, and that page explains when and why the abdomen is commonly recommended.

Our clinical team, including our lead prescriber, reviews every consultation personally before any treatment is approved. If a consultation confirms you are clinically suitable, the next step is yours to take at whatever pace makes sense for your finances. There is no subscription, no auto-renewal, no pressure.